Last reviewed · How we verify
NCT05122611
Post Lumbar Radiofrequency Neurotomy Imaging
trial testing no intervention, imaging study only in Facet Joint Pain in 10 participants. Completed in 11 January 2021.
7 January 2021
Quick facts
| Lead sponsor | FUSMobile Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 26 February 2020 |
| Primary completion | 7 January 2021 |
| Estimated completion | 11 January 2021 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- no intervention, imaging study only
Conditions studied
- Facet Joint Pain — all drugs for Facet Joint Pain →
Sponsor
FUSMobile Inc.
Who can join
18 and older, any sex, with Facet Joint Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
MRI imaging post radio frequency ablation procedure for facet arthritis
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05122611
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Facet Joint Pain
Currently open trials in the same condition.
- NCT05909709 — Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain · Phase 1 · recruiting
Other FUSMobile Inc. trials
Trials by the same sponsor.
- NCT06053255 — Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis · NA · recruiting
- NCT05396495 — Safety and Feasibility of the NeurolyserXR for Sacroiliac Joint Pain · NA · unknown
- NCT05154448 — Double Arm Pivotal Study to Evaluate the Neurolyser XR for the Treatment of Chronic Low Back Pain · NA · completed
- NCT04519541 — RAMBAM 021: Safety and Initial Feasibility of the Neurolyser XR for the Treatment of Chronic Low Back Pain · NA · completed
- NCT04129034 — Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Axial Chronic Low Back Pain · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05122611 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FUSMobile Inc.
- Last refreshed: 17 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05122611.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing